Petros Pharmaceuticals Inc (PTPI): Narxning sotuvga nisbati

Petros (PTPI) kompaniyasining korporativ logotipi

Petros Pharmaceuticals (PTPI) kompaniyasining normallashtirilgan P/S koeffitsiyenti Petros Pharmaceuticals ning bozor qiymatini aks ettiradi, bunda 0.20 belgisi ushbu parametrni tavsiflaydi. Ushbu tendentsiya retseptsiz dori vositalarining mavjudligi va komponentlar narxi bilan bog'liqdir. Barqarorlik AQSh logistikasining to'liq lokalizatsiyasi orqali ta'minlanmoqda. Shu bilan birga, biznes ekologik toza qadoqlarni joriy etmoqda va uglerod izini kamaytirib, mehnat xavfsizligining yuqori standartlarini ta'minlamoqda.

PTPI Petros Pharma Kapitalizatsiyaning daromadga nisbati (04.07.2022 - 28.06.2025)

Petros Pharmaceuticals Inc (PTPI) kompaniyasi koʻrsatkichlari kesimi va tahlili

- aksiya narxi va baholash bo'yicha konsensus prognoz:
Narxlar dinamikasi grafigi Petros Pharmaceuticals Inc|PTPI - Maqsadli narxlar grafigi
- birja kapitallashuvi ma'lumotlari:
Bozor bahosi Petros Pharma|PTPI - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya hisobiga sof aktivlar qiymati Petros Pharmaceuticals|PTPI - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga multiplikatori petrospharma.com|PTPI - Kompaniyaning jami aktivlari
- qarz majburiyatlari va likvidlik statistikasi:
Barcha qarzlarning o‘z mablag‘lariga nisbati Petros Pharmaceuticals|PTPI - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati petrospharma.com|PTPI - Kompaniya qarzlari|Sof aktivlarga qarzlar Petros Pharmaceuticals, Inc.|PTPI - Kompaniyaning uzoq muddatli majburiyatlari|Kompaniyaning qisqa muddatli kredit va qarzlari Petros Pharmaceuticals|Kritik likvidlik koeffitsiyenti petrospharma.com
- foyda va multiplikatorlar bo'yicha ma'lumotlar:
PTPI - Sof foyda|Kutilayotgan sof daromad Petros Pharmaceuticals|PTPI - P/E multiplikatori|Forvard P/E multiplikatori Petros Pharma|PTPI - Narxning foydaga va o‘sish sur’atiga nisbati|Biznes qiymatining amortizatsiya chegirilishidan oldingi operatsion foydaga nisbati Petros Pharmaceuticals|PTPI - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda Petros Pharmaceuticals|PTPI - Bir aksiya uchun sof foyda (EPS TTM)|Choraklik EPS foyda o'sishi petrospharma.com|PTPI - Joriy yilda foyda o'sishi|Keyingi yil uchun bir aksiya uchun kutilayotgan foyda o'sishi Petros Pharmaceuticals
- sotishdan tushum va biznes daromadlari ko'rsatkichlari:
PTPI - Daromad va sotish hajmi|Kompaniyaning kutilayotgan sotish hajmi Petros|PTPI - Kapitalizatsiyaning daromadga nisbati|Forvard P/S multiplikatori Petros Pharmaceuticals, Inc.
Kompaniyaning fundamental tahlili:PTPI, Petros
Petros Pharmaceuticals, Inc. tayyor mahsulotlari

Urologik dori vositalariga bo'lgan barqaror talab va Petros Pharmaceuticals (PTPI) daromadlarining sug'urta qoplamasi biznesga bozor siklliligining ta'sirini minimallashtiradi. Bozor kapitalizatsiyasining yillik daromadga nisbati sotuvlarning bir dollari qiymatini belgilaydi, bu esa investorlarga aktivlarning qadrsizlanishi va stagnatsiya o'rtasidagi muvozanatni topishga yordam beradi, bu esa P/S ko'paytirgichi vaqt grafigida yaqqol aks etgan.

Petros Pharmaceuticals kimlar bilan raqobatlashadi

HLN (Haleon) - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Kenvue Inc KVUE|Verona Pharma Corp - Narxning daromadga nisbati|MENS: Kapitalizatsiyaning daromadga nisbati|Narx/daromad koeffitsiyenti Ligand Pharmaceuticals LGND|Amneal Pharmaceuticals Inc (AMRX) - Narxning daromadga nisbati|Perrigo Company PLC - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati alvotech.com|P/S multiplikatori Liquidia Technologies|Narxning daromadga nisbati Galapagos Genomics (GLPG)|ANIP: Narxning sotuvga nisbati|P/S multiplikatori MNKD (MannKind Corp)|Narx/daromad koeffitsiyenti Amphastar (AMPH)|PCRX: Kapitalizatsiyaning daromadga nisbati|SPRY - P/S multiplikatori|Theravance Biopharma, Inc. (TBPH) - Narxning daromadga nisbati|AQST (Aquestive Therapeutics) - Narxning daromadga nisbati|SCPH (scpharmaceuticals.com) - P/S multiplikatori|TECX: Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Tonix Pharmaceuticals Inc. (TNXP)|SXTC (SXT Pharmaceuticals) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori EPRX (Eupraxia Pharmaceuticals)|Bozor kapitallashuvining daromadga nisbati BHST|Invizyne Technologies - P/S multiplikatori|oramed.com (ORMP) - Kapitalizatsiyaning daromadga nisbati|ENTX (enterabio.com) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiya va daromad nisbati HYFT|ABVC (ABVC BioPharma, Inc) - P/S multiplikatori|P/S multiplikatori cumberlandpharma.com|Narxning daromadga nisbati Quantum BioPharma (QNTM)|FibroGen (FGEN) - Narx/daromad multiplikatori|P/S multiplikatori TELO (telomirpharma.com)|RANI - Kapitalizatsiyaning daromadga nisbati|SNYR - Narxning daromadga nisbati|rallybio.com - Kapitalizatsiyaning sotish hajmiga nisbati|LEXX: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pulmatrix Inc|PTHL (Pheton Holdings) - P/S multiplikatori|Sotuvga nisbatan narx Aptorum Group Limited APM|Narxning daromadga nisbati Lyra Therapeutics (LYRA)|Kapitalizatsiyaning daromadga nisbati Impact BioMedical Inc IBO|Narxning daromadga nisbati tnfpharma.com TNFA|Bozor kapitallashuvining daromadga nisbati YCBD|PainReform Ltd - P/S multiplikatori|Altamira Therapeutics Ltd (CYTO) - Kapitalizatsiyaning daromadga nisbati|lipella.com (LIPO) - Narxning daromadga nisbati|OptiNose (OPTN) - P/S multiplikatori|PIRS (Pieris Pharmaceuticals Inc) - P/S multiplikatori|PROC: Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori QLI|SLRN - Sotuvga nisbatan narx|P/S multiplikatori TFFP (TFF Pharmaceuticals, Inc)